June 20, 2025 C-Path’s T1D Consortium to Release a Clinical Trial Simulation Tool for New-Onset Trial Design C-Path's Type 1 Diabetes Consortium today announced the release of a pilot version of their regulatory-grade new-onset clinical...
June 18, 2025 C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes C-Path's Translational Therapeutics Accelerator (TRxA) proudly announced a $250,000 grant...
May 29, 2025 Critical Path Institute and Citizen Health Partner to Accelerate Drug Development for Neuromuscular Disorders C-Path, a global nonprofit accelerating drug development through data science and regulatory...
May 27, 2025 C-Path Welcomes Avidity Biosciences as Newest Member to Duchenne Consortium C-Path is excited to welcome Avidity Biosciences as a new member of the Duchenne Regulatory Science Consortium (D-RSC). Avidity is
May 20, 2025 The Critical Path Institute Podcast: eCOA Conversations with Florence Mowlem, Karl McEvoy, and Brian Lillis Welcome to the latest Critical Path Institute Podcast episode—the first in the eCOA Conversations series.
May 12, 2025 C-Path’s Translational Therapeutics Accelerator Awards $815,000 Grant for Drug Development Project in Advanced Prostate Cancer C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today an $815,000 ($1,250,000 AUD) grant to Brian Dymock.
May 8, 2025 Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration The year 2025 marks a historic milestone for C-Path as the organization celebrates...
May 6, 2025 C-Path Announces First Data Transfer from Takeda to Accelerate Alpha-1 Innovation TUCSON, Ariz., May 6, 2025 — Critical Path Institute’s® (C-Path) Critical Path for Alpha-1 (CPA-1) consortium is proud to ann
April 25, 2025 C-Path’s CPAD Database Drives Insights into Alzheimer’s Disease C-Path’s Critical Path for Alzheimer’s Disease (CPAD) Consortium is thrilled to share...
April 25, 2025 C-Path’s Stephenson Featured in BioCentury Article C-Path Vice President of Neurology and Executive Director of Critical Path for Parkinson's (CPP) Consortium...